EUVIMEDEUVIMED entdecken
Metaanalyse

Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis

Ji Huang, Cong Cheng, Kangxin Li, Chunping Zhu, Youshun Liu

Digestive Diseases and Sciences · 2024

DOI: 10.1007/s10620-023-08258-9 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Ji Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Ganzhou People's Hospital, Ganzhou, China. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Ganzhou Municipal Health Commission of Jiangxi Province, Bureau of Science and Technology of Ganzhou Municipality, Jiangxi Provincial Bureau of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aimed to assess the effectiveness and safety of tenofovir alafenamide fumarate (TAF) in the prevention of mother-to-child transmission (MTCT) of hepatitis B virus (HBV). METHODS: We performed a meta-analysis of studies from the Cochrane Library, PubMed, ClinicalTrials.gov, Web of Science, EMBASE, China National Knowledge Infrastructure (CNKI), China Medical Information Network, and Wanfang databases. The databases were searched from inception to January 7, 2023, for cohort studies and randomized controlled trials (RCTs) comparing the use of TAF antivirals to other antivirals during pregnancy. We combined the data by means of a random-effect DerSimonian-Laird model and risk ratios (RRs) or a random-effect inverse variance model and standardized mean differences (SMDs) to determine the influence on mothers and infants. Our primary outcomes were infant weight, height, head size, birth defects, and Apgar scores. Additionally, we assessed whether newborns tested positive for hepatitis B surface antigen (HBsAg) at birth and at six months of age. The secondary outcomes of our investigation were alterations in levels of HBV deoxyribonucleic acid (DNA), alanine aminotransferase (ALT), total bilirubin (TBIL), blood creatinine, and urine β2-microglobulin (β2-M) in mothers. RESULTS: An extensive literature search identified 216 relevant publications; three cohort studies and two RCTs were included in this study. A total of 341 mothers were treated with TAF, and 342 were treated with other antiviral agents. TAF was as effective as other antiviral medications at lowering HBV MTCT rates at birth and at 6 months of age and ALT, TBIL, and HBV DNA levels. Moreover, compared with other antiviral drugs, TAF did not affect infant weight, height, head size, Apgar scores, and birth defects or maternal blood creatinine or β2-M levels. CONCLUSIONS: TAF antiviral therapy during pregnancy was found to be safe for both mothers and fetuses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BHepatitis B, ChronicFemaleHumansInfantInfant, NewbornPregnancyAdenineAntiviral AgentsCreatinineDNA, ViralFumaratesHepatitis B virusInfectious Disease Transmission, Vertical

Stichwörter der Autor:innen

Hepatitis B virus (HBV)Mother-to-child transmission (MTCT)PregnancyTenofovir alafenamide fumarate

Substanzen

AdenineAntiviral AgentsCreatinineDNA, ViralFumarates

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Ganzhou People's Hospital, Ganzhou, China.
  • Department of Infectious Disease, Successful Hospital Affiliated to Xiamen University, Xiamen, China.
  • Department of Gastroenterology, Ganzhou People's Hospital, Ganzhou, China.
  • Department of Gastroenterology, Ganzhou People's Hospital, Ganzhou, China. lys19891108@163.com.

Förderung

  • Ganzhou Municipal Health Commission of Jiangxi Province
  • Bureau of Science and Technology of Ganzhou Municipality
  • Jiangxi Provincial Bureau of Traditional Chinese Medicine

Zitieren

APA

Huang, J., Cheng, C., Li, K., Zhu, C., & Liu, Y. (2024). Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-023-08258-9

Vancouver

Huang J, Cheng C, Li K, Zhu C, Liu Y. Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-023-08258-9

BibTeX
@article{Huang2024,
  author = {Huang, Ji and Cheng, Cong and Li, Kangxin and Zhu, Chunping and Liu, Youshun},
  title = {Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  doi = {10.1007/s10620-023-08258-9}
}
Kostenlos starten →